| 
            
    
    
    
            
            
            
            
                
                    
                    
                        
                        
                        
                            
                            
 
    
        
            
                
            
            
        
    
    
        
        
        
             arxa levels are regulated by activity and the NMDAR. A–A’’, foxP2.A.2:egfp-caax and arxa are coexpressed in early development as the TCPT axons extend toward the midline. Sections, rostral top, of arxa in situ expression and Tg(foxP2.A.2:egfp-caax) α-GFP immunohistochemistry. Red boxed inset shows sense probe control for arxa. B, arxa expression is reduced following blockade (APV) or knock-down (CRISPR) of NMDAR or inhibiting activity (tricaine). qRT-PCR at 48 hpf, experimental triplicates; n > 10 embryos each group. Relative log2 fold change calculated relative to wild-type, elf1a standard, SD for each in parenthesis, p values adjusted using Benjamini–Hochberg false discovery rate; **p < 0.01; error bars, SEM. 
        
    
                        
                    
                
            
            
            
            
            
            
                
             
         |